Subscribe
lilly-logo-2--1
Photo: Courtesy of Eli Lilly
4 April 2017Big Pharma

UK Supreme Court hears Eli Lilly dispute with Actavis

A five-year dispute between Eli Lilly and Actavis over a cancer drug is being heard today at the UK Supreme Court.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.
Big Pharma
UK Supreme Court rules against Actavis in Eli Lilly patent dispute
7 July 2017   The UK Supreme Court has ruled that Actavis’s generic versions of cancer drug Alimta directly infringe patents owned by Eli Lilly, reversing two earlier decisions.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.
Big Pharma
UK Supreme Court rules against Actavis in Eli Lilly patent dispute
7 July 2017   The UK Supreme Court has ruled that Actavis’s generic versions of cancer drug Alimta directly infringe patents owned by Eli Lilly, reversing two earlier decisions.

More on this story

Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.
Big Pharma
UK Supreme Court rules against Actavis in Eli Lilly patent dispute
7 July 2017   The UK Supreme Court has ruled that Actavis’s generic versions of cancer drug Alimta directly infringe patents owned by Eli Lilly, reversing two earlier decisions.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB